• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vildagliptin-Induced Tongue Angioedema: An Uncommon Occurrence.

作者信息

Poddar Shreya, Chandra Somodyuti, Podder Indrashis

机构信息

Department of Dermatology, Asansol District Hospital, Asansol, West Bengal, India.

Consultant Dermatologist, Kolkata, West Bengal, India.

出版信息

Indian Dermatol Online J. 2024 May 20;15(4):685-686. doi: 10.4103/idoj.idoj_534_23. eCollection 2024 Jul-Aug.

DOI:10.4103/idoj.idoj_534_23
PMID:39050061
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11265730/
Abstract
摘要

相似文献

1
Vildagliptin-Induced Tongue Angioedema: An Uncommon Occurrence.维格列汀诱发的舌血管性水肿：一种罕见情况。
Indian Dermatol Online J. 2024 May 20;15(4):685-686. doi: 10.4103/idoj.idoj_534_23. eCollection 2024 Jul-Aug.
2
Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema.使用二肽基肽酶-IV抑制剂与血管紧张素转换酶抑制剂相关血管性水肿风险增加有关。
Hypertension. 2009 Sep;54(3):516-23. doi: 10.1161/HYPERTENSIONAHA.109.134197. Epub 2009 Jul 6.
3
Perindopril-induced angioedema of the lips and tongue: a case report.培哚普利引起的唇舌血管性水肿：一例报告
J Med Case Rep. 2018 Dec 5;12(1):359. doi: 10.1186/s13256-018-1910-x.
4
Angiotensin-converting enzyme inhibitor-induced unilateral tongue angioedema.血管紧张素转化酶抑制剂引起的单侧舌血管性水肿。
Am J Med Sci. 2012 Nov;344(5):416-7. doi: 10.1097/MAJ.0b013e318258317f.
5
Association between vildagliptin and risk of angioedema, foot ulcers, skin lesions, hepatic toxicity, and serious infections in patients with type 2 diabetes mellitus: A European multidatabase, noninterventional, postauthorization safety study.维格列汀与2型糖尿病患者血管性水肿、足部溃疡、皮肤病变、肝毒性及严重感染风险之间的关联：一项欧洲多数据库、非干预性、上市后安全性研究。
Endocrinol Diabetes Metab. 2019 Jun 21;2(3):e00084. doi: 10.1002/edm2.84. eCollection 2019 Jul.
6
Intramuscular lipoma of the tongue masquerading as angioedema.伪装成血管性水肿的舌部肌内脂肪瘤。
Ear Nose Throat J. 2013 Jan;92(1):E4-5. doi: 10.1177/014556131309200116.
7
Recurrence of unilateral angioedema of the tongue: A case report.单侧舌血管性水肿复发：一例报告。
World J Clin Cases. 2023 Sep 26;11(27):6603-6612. doi: 10.12998/wjcc.v11.i27.6603.
8
[Successful extubation in a patient with alacepril-induced tongue angioedema].[一名服用阿拉普利引发舌血管性水肿患者成功拔管]
Masui. 2010 Apr;59(4):519-22.
9
Life-threatening angioedema of the tongue: the detection of the RNA of B henselae in the saliva of a male patient and his dog as well as of the DNA of three Bartonella species in the blood of the patient.危及生命的舌血管性水肿：在一名男性患者及其犬类的唾液中检测到汉赛巴尔通体的RNA，以及在该患者血液中检测到三种巴尔通体属物种的DNA。
BMJ Case Rep. 2014 Mar 20;2014:bcr2013203107. doi: 10.1136/bcr-2013-203107.
10
Isolated Tongue Angioedema after Alteplase Infusion in Acute Ischemic Stroke.急性缺血性脑卒中阿替普酶输注后孤立性舌血管性水肿。
Curr Drug Saf. 2022;17(1):75-77. doi: 10.2174/1574886316666210728104331.

引用本文的文献

1
Bradykinin-Mediated Angioedema Induced by Drugs.药物诱导的缓激肽介导的血管性水肿
J Clin Med. 2025 Aug 12;14(16):5712. doi: 10.3390/jcm14165712.
2
Interaction between dipeptidyl-peptidase-4 inhibitors and drugs acting on renin angiotensin aldosterone system for the risk of angioedema: a pharmacovigilance assessment using disproportionality and interaction analyses.二肽基肽酶-4抑制剂与作用于肾素-血管紧张素-醛固酮系统的药物相互作用导致血管性水肿的风险：一项使用不成比例性分析和相互作用分析的药物警戒评估
Diabetol Metab Syndr. 2025 Jan 7;17(1):7. doi: 10.1186/s13098-024-01570-y.

本文引用的文献

1
Angioedema associated with dipeptidyl peptidase-IV inhibitors.与二肽基肽酶-IV抑制剂相关的血管性水肿
Clin Mol Allergy. 2021 Dec 6;19(1):24. doi: 10.1186/s12948-021-00164-7.
2
DPP-IV Inhibitor-Associated Angioedema in Patient With Known History of ACE Inhibitor Angioedema.二肽基肽酶-4 抑制剂相关血管性水肿患者，已知血管紧张素转换酶抑制剂相关血管性水肿病史。
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211033049. doi: 10.1177/23247096211033049.
3
Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin-Mediated vs. Mast Cell-Mediated Angioedema.
缓激肽介导的血管性水肿与肥大细胞介导的血管性水肿在机制和临床表型方面的差异与相似之处。
Clin Rev Allergy Immunol. 2021 Aug;61(1):40-49. doi: 10.1007/s12016-021-08841-w. Epub 2021 Feb 3.
4
ACE Inhibitor-Induced Angioedema: a Review.血管紧张素转换酶抑制剂相关性血管水肿：综述。
Curr Hypertens Rep. 2018 Jun 8;20(7):55. doi: 10.1007/s11906-018-0859-x.
5
Sitagliptin and Angioedema.西他列汀与血管性水肿
Ann Intern Med. 2017 Jul 18;167(2):142-143. doi: 10.7326/L16-0649. Epub 2017 May 30.
6
Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema - An Overlooked Adverse Drug Reaction?二肽基肽酶-4抑制剂诱发的血管性水肿——一种被忽视的药物不良反应？
Curr Diabetes Rev. 2018;14(4):327-333. doi: 10.2174/1573399813666170214113856.
7
Recent advances in drug-induced angioedema.药物诱导性血管性水肿的最新进展。
Allergol Int. 2012 Dec;61(4):545-57. doi: 10.2332/allergolint.12-RAI-0493.
8
Adverse drug reaction and causality assessment scales.药物不良反应及因果关系评估量表
Lung India. 2011 Apr;28(2):152-3. doi: 10.4103/0970-2113.80343.
9
Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes.在临床研究中，西格列汀的安全性和耐受性：来自 10246 例 2 型糖尿病患者数据的汇总分析。
BMC Endocr Disord. 2010 Apr 22;10:7. doi: 10.1186/1472-6823-10-7.
10
Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema.使用二肽基肽酶-IV抑制剂与血管紧张素转换酶抑制剂相关血管性水肿风险增加有关。
Hypertension. 2009 Sep;54(3):516-23. doi: 10.1161/HYPERTENSIONAHA.109.134197. Epub 2009 Jul 6.